Gene · 2938
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
| The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | 36611918 | PubTator, text mining | PubMed |
| Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. | Front Oncol | 2022 | 36568145 | PubTator, text mining | PubMed |
| Defining the Potential Targets for Biological Activity of Isoegomaketone Based on Network Pharmacology and Molecular Docking Methods. | Life (Basel) | 2022 | 36556480 | PubTator, text mining | PubMed |
| Rumen Epithelial Development- and Metabolism-Related Genes Regulate Their Micromorphology and VFAs Mediating Plateau Adaptability at Different Ages in Tibetan Sheep. | Int J Mol Sci | 2022 | 36555715 | PubTator, text mining | PubMed |
| Oxidative Stress and Intracranial Hypertension after Aneurysmal Subarachnoid Hemorrhage. | Antioxidants (Basel) | 2022 | 36552631 | PubTator, text mining | PubMed |
| Preoperative Function Assessment of Ex Vivo Kidneys with Supervised Machine Learning Based on Blood and Urine Markers Measured during Normothermic Machine Perfusion. | Biomedicines | 2022 | 36551812 | PubTator, text mining | PubMed |
| A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery. | Antibiotics (Basel) | 2022 | 36551374 | PubTator, text mining | PubMed |
| Glutathione and Its Metabolic Enzymes in Gliomal Tumor Tissue and the Peritumoral Zone at Different Degrees of Anaplasia. | Curr Issues Mol Biol | 2022 | 36547100 | PubTator, text mining | PubMed |
| The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. | Front Oncol | 2022 | 36544710 | PubTator, text mining | PubMed |
| Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. | Commun Med (Lond) | 2022 | 36473994 | PubTator, text mining | PubMed |
| The Influence of Circadian Rhythm on the Activity of Oxidative Stress Enzymes. | Int J Mol Sci | 2022 | 36430753 | PubTator, text mining | PubMed |
| Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. | Cancers (Basel) | 2022 | 36428646 | PubTator, text mining | PubMed |
| Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review. | Metabolites | 2022 | 36422285 | PubTator, text mining | PubMed |
| Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer. | Medicina (Kaunas) | 2022 | 36422199 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Biosynthesis of prostaglandin 15dPGJ2 -glutathione and 15dPGJ2-cysteine conjugates in macrophages and mast cells via MGST3. | J Lipid Res | 2022 | 36370807 | PubTator, text mining | PubMed |
| Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells. | Int J Mol Sci | 2022 | 36362202 | PubTator, text mining | PubMed |
| Interactions between folate intake and genetic predictors of gene expression levels associated with colorectal cancer risk. | Sci Rep | 2022 | 36344807 | PubTator, text mining | PubMed |
| Re-emerging concepts of immune dysregulation in autism spectrum disorders. | Front Psychiatry | 2022 | 36339838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2938/papers?page=13